Reimbursement

Latest hospital readmissions data highlight the challenges posed by septicemia

For all diagnoses across payers, researchers reported a 30-day readmission rate of 14% and an average cost per readmission of $15,200.

Nick Hut July 30, 2021

Hospital-at-home programs are gaining traction and have well-documented benefits, experts say

A Medicare waiver issued in late 2020 has spurred more health systems to implement home-care programs for acute conditions.

Nick Hut July 30, 2021

Study: In price negotiations with hospitals, self-insured employers lack leverage

The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.

Nick Hut July 29, 2021

ACO leaders support new bill designed to boost participation in value-based payment

Accountable care organizations stand to benefit from a new bill that would increase investment funding and make changes to federal ACO programs, several executives said.

Nick Hut July 26, 2021

Financial Sustainability Report: July 2021

The July 2021 issue of the Financial Sustainability Report, sponsored by Kaufman Hall, includes an account of how one health system assessed the benefits and risk associated with moving its 340B covered-entity pharmacy enterprise to a Limited Liability Company. The issue also includes a commentary on CMS’s new Acute Hospital Care at Home program and a discussion of a new metric, equivalent net patient revenue (ENPR), which organizations can use to assess the relative value of proposed investments in alternative revenue sources.

HFMA July 23, 2021

Hospital care at home signifies an important innovation in acute care delivery

Although the CMS Acute Hospital Care at Home program is still early in its development in the U.S., early adopters show evidence of the program’s exciting promise, including positive impacts on health outcomes, an improved patient and provider experience, reduced cost of care and overall healthcare savings.

Shawn Stack July 23, 2021

In 2022 OPPS rule, CMS plans to reinstate policies pertaining to the inpatient-only and ASC covered-procedures lists

The 2022 proposed rule for the Outpatient Prospective Payment System would reverse 2021 policies that began to phase out the inpatient-only list of procedures and expand the covered-procedures list for ambulatory surgical centers.

Nick Hut July 21, 2021

Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study

University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

Nathan Hagen, PharmD, MS July 21, 2021

CMS is preparing to make noncompliance with price transparency requirements much more expensive

A hospital with at least 550 beds would owe more than $2 million in penalties for a year of noncompliance with new price transparency requirements, according to a proposed rule.

Nick Hut July 20, 2021

Surveys show rates of uninsured increased, underinsured remains significant

HFMA's Chad Mulvany says healthcare organizations should ensure their self-pay revenue cycle process follows best practices as it’s likely with more people uninsured there will be increased scrutiny of these processes.

Chad Mulvany, FHFMA July 19, 2021
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );